Funding
Dr. Kitagawa has received grants and personal fees from Asahi Kasei Pharma Corporation, Ono Pharmaceutical Co., Ltd., Otsuka Pharmaceutical Factory, Inc., Nippon Covidien Inc., Taiho Pharmaceutical Co., Ltd., Chugai Pharmaceutical Co., Ltd., and Kaken Pharmaceutical Co., Ltd. Furthermore, Dr. Kitagawa received personal fees from AstraZeneca K.K., Ethicon Inc., Olympus Corporation, Shionogi Co., Ltd., and Bristol-Myers Squibb K.K. and personal fees from MSD K.K., Smith & Nephew KK, ASKA Pharmaceutical Co., Ltd., Miyarisan Pharmaceutical Co., Ltd., Toray Industries, Inc., Daiichi Sankyo Co., Ltd., Chugai Foundation for Innovative Drug Discovery Science, and Nippon Kayaku Co., Ltd. Moreover, Dr. Kitagawa has received grants from Yakult Honsha Co., Ltd., Otsuka Pharmaceutical Co., Ltd., Tsumura & Co., Sumitomo Pharma Co., Ltd., EA Pharma Co., Ltd., Eisai Co., Ltd., Kyouwa Hakkou Kirin Co., Ltd., Medicon Inc., Takeda Pharmaceutical Co., Ltd., and Teijin Pharma, Ltd.
Author information
Authors and Affiliations
Corresponding author
Additional information
Publisher's Note
Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.
Rights and permissions
About this article
Cite this article
Matsuda, S., Irino, T., Okamura, A. et al. ASO Visual Abstract: Endoscopic Evaluation of Pathologic Complete Response Using Deep Neural Network in Esophageal Cancer Patients Who Received Neoadjuvant Chemotherapy: Multicenter Retrospective Study from Four Japanese Esophageal Centers. Ann Surg Oncol 31, 2525–2526 (2024). https://doi.org/10.1245/s10434-023-14021-1
Published:
Issue Date:
DOI: https://doi.org/10.1245/s10434-023-14021-1